希少疾患診断の世界市場 2020年

• 英文タイトル：Global Rare Disease Diagnostics Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201114992 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、希少疾患診断の世界市場を調査対象にし、希少疾患診断の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血液、腫瘍）、用途別分析（病院研究所、診断研究所、遺伝子検査研究所、がん研究所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Retrophin、QIAGEN、3billion、Strand Life Sciences、23andMe、PerkinElmer、Illumina ・企業別売上、市場シェア ・希少疾患診断の地域別市場分析 ・希少疾患診断の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・希少疾患診断のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・希少疾患診断のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・希少疾患診断の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・希少疾患診断の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・希少疾患診断の種類別市場規模2015-2020：血液、腫瘍 ・希少疾患診断の用途別市場規模2015-2020：病院研究所、診断研究所、遺伝子検査研究所、がん研究所、その他 ・希少疾患診断の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Rare Disease Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Rare Disease Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Rare Disease Diagnostics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Rare Disease Diagnostics market has been segmented into:
Hematology
Oncology

By Application, Rare Disease Diagnostics has been segmented into:
Hospital Laboratories
Diagnostic Laboratories
Genetic Testing Laboratories
Cancer Research Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Rare Disease Diagnostics market presented in the report. This section sheds light on the sales growth of different regional and country-level Rare Disease Diagnostics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Rare Disease Diagnostics market.

The report offers in-depth assessment of the growth and other aspects of the Rare Disease Diagnostics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Rare Disease Diagnostics Market Share Analysis
Rare Disease Diagnostics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Rare Disease Diagnostics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Rare Disease Diagnostics sales, revenue and market share for each player covered in this report.

The major players covered in Rare Disease Diagnostics are:
Retrophin
QIAGEN
3billion
Strand Life Sciences
23andMe
PerkinElmer
Illumina

レポート目次

---

1 Rare Disease Diagnostics Market Overview
1.1 Product Overview and Scope of Rare Disease Diagnostics
1.2 Classification of Rare Disease Diagnostics by Type
1.2.1 Global Rare Disease Diagnostics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Rare Disease Diagnostics Revenue Market Share by Type in 2019
1.2.3 Hematology
1.2.4 Oncology
1.3 Global Rare Disease Diagnostics Market by Application
1.3.1 Overview: Global Rare Disease Diagnostics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Laboratories
1.3.3 Diagnostic Laboratories
1.3.4 Genetic Testing Laboratories
1.3.5 Cancer Research Laboratories
1.3.6 Others
1.4 Global Rare Disease Diagnostics Market by Regions
1.4.1 Global Rare Disease Diagnostics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Rare Disease Diagnostics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Rare Disease Diagnostics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Rare Disease Diagnostics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rare Disease Diagnostics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Rare Disease Diagnostics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rare Disease Diagnostics Status and Prospect (2015-2025)
2 Company Profiles
2.1 Retrophin
2.1.1 Retrophin Details
2.1.2 Retrophin Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Retrophin SWOT Analysis
2.1.4 Retrophin Product and Services
2.1.5 Retrophin Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.2 QIAGEN
2.2.1 QIAGEN Details
2.2.2 QIAGEN Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 QIAGEN SWOT Analysis
2.2.4 QIAGEN Product and Services
2.2.5 QIAGEN Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.3 3billion
2.3.1 3billion Details
2.3.2 3billion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 3billion SWOT Analysis
2.3.4 3billion Product and Services
2.3.5 3billion Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Strand Life Sciences
2.4.1 Strand Life Sciences Details
2.4.2 Strand Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Strand Life Sciences SWOT Analysis
2.4.4 Strand Life Sciences Product and Services
2.4.5 Strand Life Sciences Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.5 23andMe
2.5.1 23andMe Details
2.5.2 23andMe Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 23andMe SWOT Analysis
2.5.4 23andMe Product and Services
2.5.5 23andMe Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.6 PerkinElmer
2.6.1 PerkinElmer Details
2.6.2 PerkinElmer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 PerkinElmer SWOT Analysis
2.6.4 PerkinElmer Product and Services
2.6.5 PerkinElmer Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Illumina
2.7.1 Illumina Details
2.7.2 Illumina Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Illumina SWOT Analysis
2.7.4 Illumina Product and Services
2.7.5 Illumina Rare Disease Diagnostics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Rare Disease Diagnostics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Rare Disease Diagnostics Players Market Share
3.2.2 Top 10 Rare Disease Diagnostics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Rare Disease Diagnostics Revenue and Market Share by Regions
4.2 North America Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.3 Europe Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.5 South America Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
5 North America Rare Disease Diagnostics Revenue by Countries
5.1 North America Rare Disease Diagnostics Revenue by Countries (2015-2020)
5.2 USA Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.3 Canada Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
5.4 Mexico Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
6 Europe Rare Disease Diagnostics Revenue by Countries
6.1 Europe Rare Disease Diagnostics Revenue by Countries (2015-2020)
6.2 Germany Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.3 UK Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.4 France Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.5 Russia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
6.6 Italy Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Rare Disease Diagnostics Revenue by Countries
7.1 Asia-Pacific Rare Disease Diagnostics Revenue by Countries (2015-2020)
7.2 China Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.3 Japan Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.4 Korea Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.5 India Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
8 South America Rare Disease Diagnostics Revenue by Countries
8.1 South America Rare Disease Diagnostics Revenue by Countries (2015-2020)
8.2 Brazil Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
8.3 Argentina Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Rare Disease Diagnostics by Countries
9.1 Middle East & Africa Rare Disease Diagnostics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.3 UAE Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.4 Egypt Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
9.5 South Africa Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Rare Disease Diagnostics Revenue and Market Share by Type (2015-2020)
10.2 Global Rare Disease Diagnostics Market Forecast by Type (2019-2024)
10.3 Hematology Revenue Growth Rate (2015-2025)
10.4 Oncology Revenue Growth Rate (2015-2025)
11 Global Rare Disease Diagnostics Market Segment by Application
11.1 Global Rare Disease Diagnostics Revenue Market Share by Application (2015-2020)
11.2 Rare Disease Diagnostics Market Forecast by Application (2019-2024)
11.3 Hospital Laboratories Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Genetic Testing Laboratories Revenue Growth (2015-2020)
11.6 Cancer Research Laboratories Revenue Growth (2015-2020)
11.7 Others Revenue Growth (2015-2020)
12 Global Rare Disease Diagnostics Market Size Forecast (2021-2025)
12.1 Global Rare Disease Diagnostics Market Size Forecast (2021-2025)
12.2 Global Rare Disease Diagnostics Market Forecast by Regions (2021-2025)
12.3 North America Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
12.4 Europe Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
12.6 South America Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Rare Disease Diagnostics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Rare Disease Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Rare Disease Diagnostics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Rare Disease Diagnostics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Retrophin Corporate Information, Location and Competitors
Table 6. Retrophin Rare Disease Diagnostics Major Business
Table 7. Retrophin Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 8. Retrophin SWOT Analysis
Table 9. Retrophin Rare Disease Diagnostics Product and Solutions
Table 10. Retrophin Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. QIAGEN Corporate Information, Location and Competitors
Table 12. QIAGEN Rare Disease Diagnostics Major Business
Table 13. QIAGEN Rare Disease Diagnostics Total Revenue (USD Million) (2018-2019)
Table 14. QIAGEN SWOT Analysis
Table 15. QIAGEN Rare Disease Diagnostics Product and Solutions
Table 16. QIAGEN Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. 3billion Corporate Information, Location and Competitors
Table 18. 3billion Rare Disease Diagnostics Major Business
Table 19. 3billion Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 20. 3billion SWOT Analysis
Table 21. 3billion Rare Disease Diagnostics Product and Solutions
Table 22. 3billion Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Strand Life Sciences Corporate Information, Location and Competitors
Table 24. Strand Life Sciences Rare Disease Diagnostics Major Business
Table 25. Strand Life Sciences Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 26. Strand Life Sciences SWOT Analysis
Table 27. Strand Life Sciences Rare Disease Diagnostics Product and Solutions
Table 28. Strand Life Sciences Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. 23andMe Corporate Information, Location and Competitors
Table 30. 23andMe Rare Disease Diagnostics Major Business
Table 31. 23andMe Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 32. 23andMe SWOT Analysis
Table 33. 23andMe Rare Disease Diagnostics Product and Solutions
Table 34. 23andMe Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. PerkinElmer Corporate Information, Location and Competitors
Table 36. PerkinElmer Rare Disease Diagnostics Major Business
Table 37. PerkinElmer Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 38. PerkinElmer SWOT Analysis
Table 39. PerkinElmer Rare Disease Diagnostics Product and Solutions
Table 40. PerkinElmer Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Illumina Corporate Information, Location and Competitors
Table 42. Illumina Rare Disease Diagnostics Major Business
Table 43. Illumina Rare Disease Diagnostics Total Revenue (USD Million) (2017-2018)
Table 44. Illumina SWOT Analysis
Table 45. Illumina Rare Disease Diagnostics Product and Solutions
Table 46. Illumina Rare Disease Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Rare Disease Diagnostics Revenue (Million USD) by Players (2015-2020)
Table 48. Global Rare Disease Diagnostics Revenue Share by Players (2015-2020)
Table 49. Global Rare Disease Diagnostics Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Rare Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Table 51. North America Rare Disease Diagnostics Revenue by Countries (2015-2020)
Table 52. North America Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 53. Europe Rare Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Rare Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Rare Disease Diagnostics Revenue by Countries (2015-2020)
Table 56. South America Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Rare Disease Diagnostics Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Table 59. Global Rare Disease Diagnostics Revenue (Million USD) by Type (2015-2020)
Table 60. Global Rare Disease Diagnostics Revenue Share by Type (2015-2020)
Table 61. Global Rare Disease Diagnostics Revenue Forecast by Type (2021-2025)
Table 62. Global Rare Disease Diagnostics Revenue by Application (2015-2020)
Table 63. Global Rare Disease Diagnostics Revenue Share by Application (2015-2020)
Table 64. Global Rare Disease Diagnostics Revenue Forecast by Application (2021-2025)
Table 65. Global Rare Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Rare Disease Diagnostics Picture
Figure 2. Global Rare Disease Diagnostics Revenue Market Share by Type in 2019
Figure 3. Hematology Picture
Figure 4. Oncology Picture
Figure 5. Rare Disease Diagnostics Revenue Market Share by Application in 2019
Figure 6. Hospital Laboratories Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Genetic Testing Laboratories Picture
Figure 9. Cancer Research Laboratories Picture
Figure 10. Others Picture
Figure 11. Global Rare Disease Diagnostics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Rare Disease Diagnostics Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Rare Disease Diagnostics Revenue Market Share in 2019
Figure 20. Global Top 10 Players Rare Disease Diagnostics Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Rare Disease Diagnostics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Rare Disease Diagnostics Revenue Market Share by Regions (2015-2020)
Figure 24. Global Rare Disease Diagnostics Revenue Market Share by Regions in 2018
Figure 25. North America Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 26. Europe Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 28. South America Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 30. North America Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 31. North America Rare Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 32. USA Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 33. Canada Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 35. Europe Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Rare Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 37. Germany Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 38. UK Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 39. France Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 40. Russia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 41. Italy Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Rare Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 44. China Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 45. Japan Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 46. Korea Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 47. India Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 49. South America Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 50. South America Rare Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 51. Brazil Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Rare Disease Diagnostics Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Rare Disease Diagnostics Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 56. UAE Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Rare Disease Diagnostics Revenue and Growth Rate (2015-2020)
Figure 59. Global Rare Disease Diagnostics Revenue Share by Type (2015-2020)
Figure 60. Global Rare Disease Diagnostics Revenue Share by Type in 2019
Figure 61. Global Rare Disease Diagnostics Market Share Forecast by Type (2021-2025)
Figure 62. Global Hematology Revenue Growth Rate (2015-2020)
Figure 63. Global Oncology Revenue Growth Rate (2015-2020)
Figure 64. Global Rare Disease Diagnostics Revenue Share by Application (2015-2020)
Figure 65. Global Rare Disease Diagnostics Revenue Share by Application in 2019
Figure 66. Global Rare Disease Diagnostics Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital Laboratories Revenue Growth Rate (2015-2020)
Figure 68. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 69. Global Genetic Testing Laboratories Revenue Growth Rate (2015-2020)
Figure 70. Global Cancer Research Laboratories Revenue Growth Rate (2015-2020)
Figure 71. Global Others Revenue Growth Rate (2015-2020)
Figure 72. Global Rare Disease Diagnostics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Rare Disease Diagnostics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Rare Disease Diagnostics Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 76. Europe Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 78. South America Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Rare Disease Diagnostics Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel

---